Klausner Richard made one open market purchase of Lyell Immunopharma ($LYEL) shares in the past year, totaling $94,942 on March 14, 2025. This ranks 2443rd among 4983 insiders by purchase value, well below the average of $1.46 million across 3.29 transactions. He reported no open market sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 15, 2025 | Lyell Immunopharma, Inc. | $LYEL | Klausner Richard | Not found | A | Option (right to buy) | 130000 | $0.00 | 130,000.0000 | 295,228,868 | 9999.99% | 0.04% |
| March 14, 2025 | Lyell Immunopharma, Inc. | $LYEL | Klausner Richard | Not found | P | Common Stock | 158000 | $0.60 | 3,811,199.0000 | 295,228,868 | 4.32% | 0.05% |
| June 14, 2024 | Lyell Immunopharma, Inc. | $LYEL | Klausner Richard | Not found | A | Option (right to buy) | 130000 | $0.00 | 130,000.0000 | 0 | 9999.99% | 0.00% |
| Sept. 8, 2023 | Lyell Immunopharma, Inc. | $LYEL | Klausner Richard | Director | A | Option (right to buy) | 55000 | $0.00 | 55,000.0000 | 0 | 9999.99% | 0.00% |
| Aug. 15, 2023 | Lyell Immunopharma, Inc. | $LYEL | Klausner Richard | Director | S | Common Stock | 58020 | $2.28 | 3,898,714.0000 | 0 | 1.47% | 0.00% |
| June 16, 2023 | Lyell Immunopharma, Inc. | $LYEL | Klausner Richard | Director | A | Option (right to buy) | 65000 | $0.00 | 65,000.0000 | 0 | 9999.99% | 0.00% |